Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease
NCT01123369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2010-09-14
Summary
To determine the retinal and choroidal thickness in patients with sickle cell disease compared to age, race matched population without sickle cell disease to allow a better understanding of the clinical manifestations of sickle cell retinopathy. The purpose of this research study is to evaluate the relationship between sickle cell disease and the eye. The research study is recruiting African American population with or without Sickle Cell Disease. The investigator in charge of this study is Dr E. Bowie. Approximately 60 subjects of both sexes will be enrolled at the Medical University of South Carolina.
Conditions
Sponsors & Collaborators
-
Medical University of South Carolina
lead OTHER
Principal Investigators
-
Esther M Bowie, MD · Medical University of South Carolina, Storm Eye Institute
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
Countries
- United States
Study Locations
More Related Trials
-
Liver Fibrosis in Sickle Cell Disease
NCT02007746 ·Status: COMPLETED
-
Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging
NCT03478917 ·Status: COMPLETED
-
Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease
NCT02447627 ·Status: COMPLETED
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease
NCT02946905 ·Status: COMPLETED
-
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease
NCT00528801 ·Status: COMPLETED
-
Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant
NCT03458897 ·Status: COMPLETED ·Phase: NA
-
Carbon Monoxide Levels and Sickle Cell Disease Severity
NCT01547793 ·Status: COMPLETED
-
QST-Pupillometry in Sickle Cell Disease Patients
NCT02242058 ·Status: COMPLETED
-
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
NCT01389024 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy
NCT06396403 ·Status: COMPLETED
-
Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease
NCT06345638 ·Status: COMPLETED
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Sickle Cell Hemoglobinopathies and Bone Health
NCT02306993 ·Status: ACTIVE_NOT_RECRUITING
-
Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers
NCT05833022 ·Status: COMPLETED
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study
NCT01888614 ·Status: WITHDRAWN
-
The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell Disease
NCT00451919 ·Status: COMPLETED
-
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
NCT03288012 ·Status: UNKNOWN
-
Sickle Cell Trait in Football Players
NCT01891877 ·Status: UNKNOWN
-
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia
NCT04380610 ·Status: COMPLETED
-
Acute Kidney Injury in Patients With Sickle Cell Disease
NCT03105271 ·Status: COMPLETED
-
Nephropathy in Patients With Sickle Cell Disease
NCT03680547 ·Status: UNKNOWN
-
COVID-19 Vaccine Response in Sickle Cell Disease
NCT05139992 ·Status: COMPLETED
-
Cardiovascular Complications of Sickle Cell Disease
NCT01044901 ·Status: COMPLETED